Principal Securities’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$861K Buy
5,265
+144
+3% +$22.1K 0.01% 770
2025
Q4
$891K Sell
5,121
-1,883
-27% -$344K 0.01% 728
2025
Q3
$1.01M Buy
7,004
+1,283
+22% +$157K 0.02% 662
2025
Q2
$576K Buy
5,721
+2,582
+82% +$197K 0.01% 802
2025
Q1
$217K Hold
3,139
﹤0.01% 1092
2024
Q4
$217K Buy
3,139
+1,120
+55% +$80.7K ﹤0.01% 1092
2024
Q3
$147K Sell
2,019
-40
-2% -$2.95K ﹤0.01% 1227
2024
Q2
$138K Buy
2,059
+1,767
+605% +$68.5K ﹤0.01% 1195
2024
Q1
$7.92K Sell
292
-107
-27% -$3K ﹤0.01% 2442
2023
Q4
$12.4K Buy
+399
New +$10.3K ﹤0.01% 2145

Other funds holding INSM

Principal Securities's INSM Position: Q1 2026 in Review

Principal Securities increased its Insmed (INSM) stake by 2.8% in Q1 2026, buying an estimated $22.1K and bringing the position to 5,265 shares worth $861K. The position accounts for 0.01% of the portfolio, ranked #770.

Principal Securities first reported a position in INSM in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.01M in Q3 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Principal Securities held 5,265 shares of Insmed worth $861K as of Q1 2026.
  • Principal Securities bought 144 Insmed shares in Q1 2026, an estimated $22.1K.
  • Insmed made up 0.01% of Principal Securities's portfolio in Q1 2026, its #770 holding.
  • Principal Securities first reported a position in Insmed in Q4 2023 and has held it in 10 quarters since.
  • Principal Securities's Insmed position peaked at $1.01M in Q3 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.